Year |
Citation |
Score |
2023 |
McInturff EL, France SP, Leverett CA, Flick AC, Lindsey EA, Berritt S, Carney DW, DeForest JC, Ding HX, Fink SJ, Gibson TS, Gray K, Hubbell AK, Johnson AM, Liu Y, et al. Synthetic Approaches to the New Drugs Approved During 2021. Journal of Medicinal Chemistry. PMID 37528515 DOI: 10.1021/acs.jmedchem.3c00501 |
0.786 |
|
2022 |
Flick AC, Leverett CA, Ding HX, McInturff EL, Fink SJ, Mahapatra S, Carney DW, Lindsey EA, DeForest JC, France SP, Berritt S, Bigi-Botterill SV, Gibson TS, Watson RB, Liu Y, et al. Synthetic Approaches to the New Drugs Approved During 2020. Journal of Medicinal Chemistry. PMID 35833579 DOI: 10.1021/acs.jmedchem.2c00710 |
0.786 |
|
2021 |
Flick AC, Leverett CA, Ding HX, McInturff E, Fink SJ, Mahapatra S, Carney DW, Lindsey EA, DeForest JC, France SP, Berritt S, Bigi-Botterill SV, Gibson TS, Liu Y, O'Donnell CJ. Synthetic Approaches to the New Drugs Approved during 2019. Journal of Medicinal Chemistry. PMID 33783211 DOI: 10.1021/acs.jmedchem.1c00208 |
0.784 |
|
2020 |
Flick A, Leverett CA, Ding HX, McInturff EL, Fink S, Helal C, Deforest J, Morse P, Mahapatra S, O'Donnell CJ. Synthetic Approaches to the New Drugs Approved During 2018. Journal of Medicinal Chemistry. PMID 32338902 DOI: 10.1021/Acs.Jmedchem.0C00345 |
0.795 |
|
2019 |
Flick AC, Leverett CA, Ding HX, McInturff EL, Fink SJ, Helal CJ, O'Donnell CJ. Synthetic Approaches to the New Drugs Approved During 2017. Journal of Medicinal Chemistry. PMID 30939001 DOI: 10.1021/acs.jmedchem.9b00196 |
0.795 |
|
2018 |
Flick A, Ding HX, Leverett CA, Fink SJ, O'Donnell CJ. Synthetic Approaches to New Drugs Approved During 2016. Journal of Medicinal Chemistry. PMID 29620889 DOI: 10.1021/acs.jmedchem.8b00260 |
0.796 |
|
2017 |
Flick AC, Ding HX, Leverett CA, Kyne RE, Liu KK, Fink SJ, O'Donnell CJ. Correction to Synthetic Approaches to the New Drugs Approved During 2015. Journal of Medicinal Chemistry. PMID 29035530 DOI: 10.1021/Acs.Jmedchem.7B01452 |
0.769 |
|
2017 |
Flick AC, Ding HX, Leverett CA, Kyne RE, Liu KK, Fink SJ, O'Donnell CJ. Synthetic Approaches to New Drugs Approved During 2015. Journal of Medicinal Chemistry. PMID 28421763 DOI: 10.1021/acs.jmedchem.7b00010 |
0.796 |
|
2016 |
Leverett CA, Sukuru SC, Vetelino BC, Musto S, Parris K, Pandit J, Loganzo F, Varghese AH, Bai G, Liu B, Liu D, Hudson S, Doppalapudi VR, Stock J, O'Donnell CJ, et al. Design, Synthesis, and Cytotoxic Evaluation of Novel Tubulysin Analogues as ADC Payloads. Acs Medicinal Chemistry Letters. 7: 999-1004. PMID 27882198 DOI: 10.1021/Acsmedchemlett.6B00274 |
0.414 |
|
2016 |
Leverett CA, Li G, France S, Padwa A. An IMDAF Cascade Approach Toward the Synthesis of the Alkaloid (+/-)-Minfiensine. The Journal of Organic Chemistry. PMID 27214235 DOI: 10.1021/Acs.Joc.6B00771 |
0.54 |
|
2016 |
Flick AC, Ding HX, Leverett CA, Kyne RE, Liu KK, Fink SJ, O'Donnell CJ. Synthetic approaches to the 2014 new drugs. Bioorganic & Medicinal Chemistry. PMID 27020685 DOI: 10.1016/j.bmc.2016.03.004 |
0.79 |
|
2015 |
Ding HX, Leverett CA, Kyne RE, Liu KK, Fink SJ, Flick AC, O'Donnell CJ. Synthetic approaches to the 2013 new drugs. Bioorganic & Medicinal Chemistry. 23: 1895-922. PMID 25797159 DOI: 10.1016/J.Bmc.2015.02.056 |
0.79 |
|
2015 |
Maderna A, Leverett CA. Recent advances in the development of new auristatins: structural modifications and application in antibody drug conjugates. Molecular Pharmaceutics. 12: 1798-812. PMID 25697404 DOI: 10.1021/mp500762u |
0.42 |
|
2014 |
Maderna A, Doroski M, Subramanyam C, Porte A, Leverett CA, Vetelino BC, Chen Z, Risley H, Parris K, Pandit J, Varghese AH, Shanker S, Song C, Sukuru SC, Farley KA, et al. Discovery of cytotoxic dolastatin 10 analogues with N-terminal modifications. Journal of Medicinal Chemistry. 57: 10527-43. PMID 25431858 DOI: 10.1021/jm501649k |
0.327 |
|
2014 |
Ding HX, Leverett CA, Kyne RE, Liu KKC, Sakya SM, Flick AC, O'Donnell CJ. Synthetic approaches to the 2012 new drugs Bioorganic and Medicinal Chemistry. 22: 2005-2032. PMID 24629448 DOI: 10.1016/J.Bmc.2014.02.017 |
0.792 |
|
2012 |
Leverett CA, Purohit VC, Johnson AG, Davis RL, Tantillo DJ, Romo D. Dyotropic rearrangements of fused tricyclic β-lactones: application to the synthesis of (-)-curcumanolide A and (-)-curcumalactone. Journal of the American Chemical Society. 134: 13348-56. PMID 22853802 DOI: 10.1021/Ja303414A |
0.303 |
|
2009 |
Kiren S, Hong X, Leverett CA, Padwa A. Synthesis of 2,4-disubstituted pyrroles by rearrangements of 2-furanyl carbamates. Organic Letters. 11: 1233-5. PMID 19231853 DOI: 10.1021/Ol900059E |
0.49 |
|
2009 |
Bobeck DR, France S, Leverett CA, Sánchez-Cantalejo F, Padwa A. Cycloaddition studies directed toward the strychnos alkaloid minfiensine Tetrahedron Letters. 50: 3145-3147. DOI: 10.1016/J.Tetlet.2008.12.088 |
0.473 |
|
2009 |
Kiren S, Hong X, Leverett CA, Padwa A. A facile synthesis of 5-alkoxypyrrol-2(5H)-ones using a modified aza-Achmatowicz oxidation Tetrahedron. 65: 6720-6729. DOI: 10.1016/J.Tet.2009.03.011 |
0.494 |
|
2009 |
Padwa A, Leverett CA, Hong X. A novel oxidative rearrangement of N-furanyl carbamates uncovered during a planned synthesis of a daphniphyllum alkaloid Acta Chimica Slovenica. 56: 527-534. |
0.356 |
|
2008 |
France S, Boonsombat J, Leverett CA, Padwa A. Cycloaddition across the benzofuran ring as an approach to the morphine alkaloids. The Journal of Organic Chemistry. 73: 8120-3. PMID 18788783 DOI: 10.1021/Jo8016956 |
0.688 |
|
2006 |
Leverett CA, Cassidy MP, Padwa A. Application of the aza-Achmatowicz oxidative rearrangement for the stereoselective synthesis of the Cassia and Prosopis alkaloid family. The Journal of Organic Chemistry. 71: 8591-601. PMID 17064038 DOI: 10.1021/Jo0616714 |
0.676 |
|
2004 |
Padwa A, Flick AC, Leverett CA, Stengel T. Rhodium(II)-catalyzed aziridination of allyl-substituted sulfonamides and carbamates. The Journal of Organic Chemistry. 69: 6377-86. PMID 15357598 DOI: 10.1021/Jo048990K |
0.678 |
|
2002 |
Jackson MM, Leverett C, Toczko JF, Roberts JC. An unexpected equilibrium process associated with a standard approach to ynone synthesis Journal of Organic Chemistry. 67: 5032-5035. PMID 12098333 DOI: 10.1021/Jo025682I |
0.376 |
|
Show low-probability matches. |